Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
Crossref DOI link: https://doi.org/10.1007/s40801-018-0130-4
Published Online: 2018-01-23
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lafeuille, Marie-Hélène
Tandon, Neeta
Tiggelaar, Sean
Kamstra, Rhiannon http://orcid.org/0000-0001-7003-7907
Lefebvre, Patrick
Kim, Edward
Yue, Yong
Joshi, Kruti
Funding for this research was provided by:
Janssen Scientific Affairs, LLC
License valid from 2018-01-23